141 related articles for article (PubMed ID: 12653682)
1. Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome.
Chan DC; Watts GF; Barrett PH; O'Neill FH; Redgrave TG; Thompson GR
Clin Sci (Lond); 2003 Apr; 104(4):383-8. PubMed ID: 12653682
[TBL] [Abstract][Full Text] [Related]
2. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
[TBL] [Abstract][Full Text] [Related]
3. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
Chan DC; Watts GF; Barrett PH; Mamo JC; Redgrave TG
Clin Chem; 2002 Feb; 48(2):278-83. PubMed ID: 11805008
[TBL] [Abstract][Full Text] [Related]
4. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR
Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism.
Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
Clin Chem; 2005 Mar; 51(3):578-85. PubMed ID: 15650029
[TBL] [Abstract][Full Text] [Related]
6. Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
Dane-Stewart CA; Watts GF; Mamo JC; Barrett PH; Martins IJ; Dimmitt SB; Redgrave TG
Eur J Clin Invest; 2002 Jul; 32(7):493-9. PubMed ID: 12153549
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
Chan DC; Watts GF; Barrett PH; Martins IJ; James AP; Mamo JC; Mori TA; Redgrave TG
J Lipid Res; 2002 May; 43(5):706-12. PubMed ID: 11971941
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men.
Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH
Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790
[TBL] [Abstract][Full Text] [Related]
9. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
[TBL] [Abstract][Full Text] [Related]
10. Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia.
Dane-Stewart CA; Watts GF; Mamo JC; Dimmitt SB; Barrett PH; Redgrave TG
Eur J Clin Invest; 2001 Feb; 31(2):113-7. PubMed ID: 11168448
[TBL] [Abstract][Full Text] [Related]
11. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides.
Karpe F; Boquist S; Tang R; Bond GM; de Faire U; Hamsten A
J Lipid Res; 2001 Jan; 42(1):17-21. PubMed ID: 11160361
[TBL] [Abstract][Full Text] [Related]
12. Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome.
Watts GF; Chan DC; Barrett PH; O'Neill FH; Thompson GR
Int J Obes Relat Metab Disord; 2003 Jul; 27(7):862-5. PubMed ID: 12821974
[TBL] [Abstract][Full Text] [Related]
13. Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
Chan DC; Wong AT; Pang J; Barrett PH; Watts GF
Clin Sci (Lond); 2015 Mar; 128(6):379-85. PubMed ID: 25291660
[TBL] [Abstract][Full Text] [Related]
14. Plasma markers of cholesterol homeostasis in metabolic syndrome subjects with or without type-2 diabetes.
Ooi EM; Ng TW; Chan DC; Watts GF
Diabetes Res Clin Pract; 2009 Sep; 85(3):310-6. PubMed ID: 19573945
[TBL] [Abstract][Full Text] [Related]
15. Kidney function, cholesterol absorption and remnant lipoprotein accumulation in patients with diabetes mellitus.
Sonoda M; Shoji T; Kimoto E; Okute Y; Shima H; Naganuma T; Motoyama K; Morioka T; Mori K; Fukumoto S; Shioi A; Koyama H; Emoto M; Inaba M
J Atheroscler Thromb; 2014; 21(4):346-54. PubMed ID: 24335047
[TBL] [Abstract][Full Text] [Related]
16. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus.
Dane-Stewart CA; Watts GF; Barrett PH; Stuckey BG; Mamo JC; Martins IJ; Redgrave TG
Clin Endocrinol (Oxf); 2003 Apr; 58(4):415-20. PubMed ID: 12641623
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
Batista MC; Welty FK; Diffenderfer MR; Sarnak MJ; Schaefer EJ; Lamon-Fava S; Asztalos BF; Dolnikowski GG; Brousseau ME; Marsh JB
Metabolism; 2004 Oct; 53(10):1255-61. PubMed ID: 15375779
[TBL] [Abstract][Full Text] [Related]
18. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
19. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
